Sublineages of Mycobacterium tuberculosis Beijing genotype strains and unfavorable outcomes of anti-tuberculosis treatment

WHO. Global tuberculosis report 2013. http://www.who.int/tb/publications/global_report/en/ [Date last accessed 05.10.14]. Faustini, 2006, Risk factors for multidrug resistant tuberculosis in Europe: a systematic review, Thorax, 61, 158, 10.1136/thx.2005.045963 Wang, 2007, Prediction of the tuberculosis reinfection proportion from the local incidence, J Infect Dis, 196, 281, 10.1086/518898 Panjabi, 2007, Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk, Int J Tuberc Lung Dis, 11, 828 Chang, 2004, A nested case-control study on treatment-related risk factors for early relapse of tuberculosis, Am J Respir Crit Care Med, 170, 1124, 10.1164/rccm.200407-905OC Lew, 2008, Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis, Ann Intern Med, 149, 123, 10.7326/0003-4819-149-2-200807150-00008 Hanekom, 2011, Mycobacterium tuberculosis Beijing genotype: a template for success, Tuberculosis (Edinb), 91, 510, 10.1016/j.tube.2011.07.005 Comas, 2013, Out-of-Africa migration and neolithic coexpansion of Mycobacterium tuberculosis with modern humans, Nat Genet, 45, 1176, 10.1038/ng.2744 European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis, 2006, Beijing/W genotype Mycobacterium tuberculosis and drug resistance, Emerg Infect Dis, 12, 736, 10.3201/eid1205.050400 Lan, 2003, Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam, Emerg Infect Dis, 9, 1633, 10.3201/eid0912.030169 Sun, 2006, Association of Mycobacterium tuberculosis Beijing genotype with tuberculosis relapse in Singapore, Epidemiol Infect, 134, 329, 10.1017/S095026880500525X Burman, 2009, Relapse associated with active disease caused by Beijing strain of Mycobacterium tuberculosis, Emerg Infect Dis, 15, 1061, 10.3201/eid1507.081253 Huyen, 2013, Tuberculosis relapse in Vietnam is significantly associated with Mycobacterium tuberculosis Beijing genotype infections, J Infect Dis, 207, 1516, 10.1093/infdis/jit048 Ribeiro, 2014, Mycobacterium tuberculosis strains of the modern sublineage of the Beijing family are more likely to display increased virulence than strains of the ancient sublineage, J Clin Microbiol, 52, 2615, 10.1128/JCM.00498-14 Hanekom, 2007, A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease, J Clin Microbiol, 45, 1483, 10.1128/JCM.02191-06 Iwamoto, 2012, Genetic diversity and transmission characteristics of Beijing family strains of Mycobacterium tuberculosis in Peru, PLoS One, 7, e49651, 10.1371/journal.pone.0049651 Iwamoto, 2008, Population structure analysis of the Mycobacterium tuberculosis Beijing family indicates an association between certain sublineages and multidrug resistance, Antimicrob Agents Chemother, 52, 3805, 10.1128/AAC.00579-08 Mokrousov, 2006, Evolution of drug resistance in different sublineages of Mycobacterium tuberculosis Beijing genotype, Antimicrob Agents Chemother, 50, 2820, 10.1128/AAC.00324-06 Maeda, 2014, Mycobacterium tuberculosis strains spreading in Hanoi, Vietnam: Beijing sublineages, genotypes, drug susceptibility patterns, and host factors, Tuberculosis (Edinb), 94, 649, 10.1016/j.tube.2014.09.005 Kremer, 2009, Vaccine-induced immunity circumvented by typical Mycobacterium tuberculosis Beijing strains, Emerg Infect Dis, 15, 335, 10.3201/eid1502.080795 Hang, 2014, Association between tuberculosis recurrence and interferon-γ response during treatment, J Infect, 69, 616 Hang, 2013, Primary drug-resistant tuberculosis in Hanoi, Viet Nam: present status and risk factors, PLoS One, 8, e71867, 10.1371/journal.pone.0071867 Nakajima, 2013, Simple multiplex PCR assay for identification of Beijing family Mycobacterium tuberculosis isolates with a lineage-specific mutation in Rv0679c, J Clin Microbiol, 51, 2025, 10.1128/JCM.03404-12 Kamerbeek, 1997, Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology, J Clin Microbiol, 35, 907, 10.1128/JCM.35.4.907-914.1997 Brudey, 2006, Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology, BMC Microbiol, 6, 23, 10.1186/1471-2180-6-23 Wada, 2009, Genetic diversity of the Mycobacterium tuberculosis Beijing family in East Asia revealed through refined population structure analysis, FEMS Microbiol Lett, 291, 35, 10.1111/j.1574-6968.2008.01431.x Supply, 2006, Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis, J Clin Microbiol, 44, 4498, 10.1128/JCM.01392-06 Allix-Beguec, 2014, Proposal of a consensus set of hypervariable mycobacterial interspersed repetitive-unit-variable-number tandem-repeat loci for subtyping of Mycobacterium tuberculosis Beijing isolates, J Clin Microbiol, 52, 164, 10.1128/JCM.02519-13 MacGregor, 1975, The significance of isolating low numbers of mycobacterium tuberculosis in culture of sputum specimens, Chest, 68, 518, 10.1378/chest.68.4.518 Hales, 2013, The association between symptoms and microbiologically defined response to tuberculosis treatment, Ann Am Thorac Soc, 10, 18, 10.1513/AnnalsATS.201207-038OC Coscolla, 2014, Consequences of genomic diversity in Mycobacterium tuberculosis, Semin Immunol, 26, 431, 10.1016/j.smim.2014.09.012 Quy, 2003, Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?, Int J Tuberc Lung Dis, 7, 631 Jindani, 2004, Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial, Lancet, 364, 1244, 10.1016/S0140-6736(04)17141-9 Vree, 2007, Survival and relapse rate of tuberculosis patients who successfully completed treatment in Vietnam, Int J Tuberc Lung Dis, 11, 392 Espinal, 2000, Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries, JAMA, 283, 2537, 10.1001/jama.283.19.2537 Yang, 2012, Mycobacterium tuberculosis Beijing strains favor transmission but not drug resistance in China, Clin Infect Dis, 55, 1179, 10.1093/cid/cis670 van Laarhoven, 2013, Low induction of proinflammatory cytokines parallels evolutionary success of modern strains within the Mycobacterium tuberculosis Beijing genotype, Infect Immun, 81, 3750, 10.1128/IAI.00282-13 Chen, 2014, The pattern of cytokine production in vitro induced by ancient and modern Beijing Mycobacterium tuberculosis strains, PLoS One, 9, e94296, 10.1371/journal.pone.0094296 WHO. Treatment of tuberculosis Guideline. 4th ed. http://www.who.int/tb/publications/tb_treatmentguidelines/en/ [Date last accessed 05.10.14]. Jiménez-Corona, 2013, Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes, Thorax, 68, 214, 10.1136/thoraxjnl-2012-201756 Horne, 2010, Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis, Lancet Infect Dis, 10, 387, 10.1016/S1473-3099(10)70071-2